The Phase 2 trial (NCT03675477) employed a randomized, double-blind, placebo-controlled, multicenter design with 164 participants testing three different dosing regimens (4mg daily, 4mg twice daily, and 8mg daily) against placebo over an initial 8-week period, followed by an optional 8-week extension Phase where placebo patients were re-randomized to active treatment arms
Patients who begin now take the first step toward long-term improvements
(Side Effects & Risks) AOD-9604 is generally considered safe and well-tolerated, but like any peptide, it comes with potential side effects and risks
Getting aerosol treatment is especially important if the air you breathe is the core problem
Cobys phone line at (312) 971-8711 rings to a real person on weekdays, and they were polite and helpful
Even after just a few weeks, tangible improvements are often evident, contributing to your overall well-being beyond basic weight loss expectations